Novel approaches to pathogenesis. Diagnosis and treatment of autoimmune diseases based on new insights into Thymus-dependent self.tolerance. EUROTHYMAIDE

Project Details


Summary not available
Effective start/end date1/01/0431/12/08

Collaborative partners

  • University of Liège (ULiège) (lead)
  • The Chancellor, Masters And Scholars of the University Of Oxford
  • Ludwig Maximilian University of Munich (LMU)
  • Apeiron Biologics
  • The University of Birmingham
  • Centre Hospitalier Regional et Universitaire de Lille
  • French National Centre for Scientific Research (CNRS)
  • Deutsches Krebsforschungszentrum Heildeberg-German Cancer Research Center
  • Fit Biotech Oyj PLC
  • Ingenium Pharmaceuticals AG
  • French Institute of Health and Medical Research
  • King's College London
  • Max Planck Society
  • Austrian Academy of Sciences
  • Research Institute of Molecular Pathology
  • University of Basel
  • University of Montreal (UdeM)
  • Tartu Ülikool (University of Tartu)
  • Università degli Studi di Roma-Sapienza
  • The Walter and Eliza Hall Institute for Medical Research
  • Zentech
  • Universitat Autònoma de Barcelona (UAB)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.